On December 3, 2024, 180 Life Sciences appointed Stephen H. Shoemaker to its Board of Directors, following the resignation of Omar Jimenez. Mr. Shoemaker, a seasoned executive with extensive experience in finance and strategic planning, will serve as a Class I director until the 2025 Annual Meeting.Mr. Shoemaker's appointment strengthens the Board's independence and compliance with Nasdaq's Listing Rule 5605(c)(2). He brings expertise in the gaming and eSports sectors, having previously led WIN Group and Engine Media Holdings. His strategic insights are expected to support 180's pivot into the entertainment and iGaming sectors.Mr. Jimenez will continue as CFO, focusing on financial leadership. The company anticipates leveraging Mr. Shoemaker's experience to drive growth and capitalize on new market opportunities.

On December 3, 2024, 180 Life Sciences appointed Stephen H. Shoemaker to its Board of Directors, following the resignation of Omar Jimenez. Mr. Shoemaker, a seasoned executive with extensive experience in finance and strategic planning, will serve as a Class I director until the 2025 Annual Meeting.Mr. Shoemaker's appointment strengthens the Board's independence and compliance with Nasdaq's Listing Rule 5605(c)(2). He brings expertise in the gaming and eSports sectors, having previously led WIN Group and Engine Media Holdings. His strategic insights are expected to support 180's pivot into the entertainment and iGaming sectors.Mr. Jimenez will continue as CFO, focusing on financial leadership. The company anticipates leveraging Mr. Shoemaker's experience to drive growth and capitalize on new market opportunities.